Hemostemix (HEM) News Today C$0.08 +0.01 (+6.25%) (As of 11/20/2024 05:33 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private PlacementOctober 31, 2024 | finance.yahoo.comTUGAF TUGA Innovations, Inc.October 26, 2024 | seekingalpha.comHemostemix's Private PlacementOctober 11, 2024 | finance.yahoo.comHemostemix Inc. (CVE:HEM) Director Sells C$21,612.50 in StockOctober 9, 2024 | insidertrades.comCanadian Investment Regulatory Organization Trade Resumption - HEMAugust 2, 2024 | ca.finance.yahoo.comHemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01August 2, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - HEMAugust 1, 2024 | finance.yahoo.comClosing Bell: Hemostemix Inc flat on Monday (HEM)July 24, 2024 | theglobeandmail.comGlobal Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsightMay 2, 2024 | finance.yahoo.comHemostemix Inc.: Hemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finanznachrichten.deHemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finance.yahoo.comHemostemix: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (HEM)February 20, 2024 | theglobeandmail.comHemostemix: Top 10 Undervalued Biotechnology Industry Stocks (HEM)February 19, 2024 | theglobeandmail.comHemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental SciencesFebruary 6, 2024 | finance.yahoo.comHemostemix Inc HMTXFJanuary 19, 2024 | morningstar.comHemostemix Inc.: Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finanznachrichten.deHemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc down on Thursday (HEM)October 20, 2023 | theglobeandmail.comHemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant ApplicationsAugust 29, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc up on Friday (HEM)August 8, 2023 | theglobeandmail.comHemostemix Inc.: Hemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | finanznachrichten.deClosing Bell: Hemostemix Inc up on Tuesday (HEM)June 28, 2023 | theglobeandmail.comHemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc down on Monday (HEM)June 27, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Wednesday (HEM)June 24, 2023 | theglobeandmail.comHemostemix's Private Placement Use of ProceedsJune 22, 2023 | marketwatch.comClosing Bell: Hemostemix Inc down on Friday (HEM)June 17, 2023 | theglobeandmail.comHemostemix to raise $1.2M through private placement of unitsJune 2, 2023 | msn.comClosing Bell: Hemostemix Inc flat on Tuesday (HEM)May 3, 2023 | theglobeandmail.comHemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant CompanyMay 2, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc flat on Friday (HEM)April 29, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Thursday (HEM)April 21, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Wednesday (HEM)April 20, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Tuesday (HEM)April 19, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Monday (HEM)April 18, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc down on Wednesday (HEM)April 13, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc up on Thursday (HEM)April 7, 2023 | theglobeandmail.comHemostemix' Second Round Interviews with Executive Vice President Business Development CandidatesApril 3, 2023 | finance.yahoo.comPeripheral Artery Disease Market to Showcase Growth at a Paltry CAGR of 4% During the Study Period (2019-2032) | DelveInsightMarch 29, 2023 | finance.yahoo.comHemostemix Closes $762,400 of The Unit Private PlacementMarch 21, 2023 | finance.yahoo.comHemostemix Unit Offering RepricedMarch 8, 2023 | finance.yahoo.comThe Force Family Office Engaged by HemostemixJanuary 31, 2023 | yahoo.comHemostemix' "Your Fountain of Youth" Trademark Granted by SwitzerlandJanuary 30, 2023 | finance.yahoo.comHemostemix' "Your Fountain of Youth" Trademark Granted by Japan Patent OfficeJanuary 26, 2023 | benzinga.comCritical Limb Ischemia Drug Market 2023 : Company Profile Analysis, Industry Segmentation, Opportunity Assessment and Forecast by 2028January 26, 2023 | marketwatch.comHemostemix Wins Arbitration DecisionJanuary 24, 2023 | finance.yahoo.comHEM.V - | Stock Price & Latest News | ReutersJanuary 23, 2023 | reuters.comHemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund Up To 75% of 5-Year CostsJanuary 23, 2023 | benzinga.comHemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre FoundationJanuary 19, 2023 | benzinga.comCritical Limb Ischemia Drug Market 2023 to 2028 SWOT Analysis & Consumer Demographics Trends with Prominent PlayersJanuary 17, 2023 | marketwatch.com Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! HEM Media Mentions By Week HEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEM News Sentiment▼0.000.47▲Average Medical News Sentiment HEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEM Articles This Week▼00▲HEM Articles Average Week Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aeterna Zentaris News Sirona Biochem News Resverlogix News Kane Biotech News Aptose Biosciences News Innovotech News Quest PharmaTech News Fennec Pharmaceuticals News Medicenna Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:HEM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
